MARK BOULES, M.D.
Student in an Organized Health Care Education/Training Program in YAKIMA, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARK BOULES, M.D. filed 2,022 Medicare Part D claims in 2023 as a Student in an Organized Health Care Education/Training Program in YAKIMA, Washington, prescribing 87% generic.
- 2K
- Part D claims, 2023
- 87%
- generic prescribing
- $229.86
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARK BOULES, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,022 Top 16% higher than 84% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about MARK BOULES, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Washington
How Student in an Organized Health Care Education/Training Program compares to other specialties among Washington providers
Student in an Organized Health Care Education/Training Program share within Washington
Student in an Organized Health Care Education/Training Program is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Student in an Organized Health Care Education/Training Program (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Student in an Organized Health Care Education/Training Program ABMS/AOA estimate
Est. board-certified rate (Student in an Organized Health Care Education/Training Program) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Student in an Organized Health Care Education/Training Program US NPIs
Specialty board-certified rate — Student in an Organized Health Care Education/Training Program estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARK BOULES, M.D. appears in the CMS NPPES registry as a Student in an Organized Health Care Education/Training Program provider holding M.D. credentials at 1806 W LINCOLN AVE, YAKIMA, WA, 98902, with a listed phone of (509) 452-4520. NPI 1477117596 was issued on 04/24/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOULES most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,022 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $209K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 2.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Student in an Organized Health Care Education/Training Program is a high-volume specialty nationwide, with 331,761 enrolled providers across 55 states and an average of 459 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477117596 |
|---|---|
| Specialty | Student in an Organized Health Care Education/Training Program |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/24/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARK BOULES, M.D.'s current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MARK BOULES, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BOULES, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$230
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to MARK BOULES, M.D.. To verify MARK BOULES, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 2,022 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,439
- Total Day Supply
- 95,015
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $172K
- Generic Drug Cost
- $36K
- Opioid Claims
- 58 (2.9% rate)
- Antibiotic Claims
- 105
Patient Demographics
- Average Patient Age
- 70.7 years
- Avg HCC Risk Score
- 1.31
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 40, 65-74: 68, 75-84: 60, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARK BOULES, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
99 claims
- Lisinopril
Lisinopril
71 claims
- Omeprazole
Omeprazole
66 claims
- Levothyroxine Sodium
Levothyroxine Sodium
58 claims
- Amlodipine Besylate
Amlodipine Besylate
56 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
54 claims
- Escitalopram Oxalate
Escitalopram Oxalate
54 claims
- Metformin Hcl
Metformin Hcl
50 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 99 |
| Lisinopril | 71 |
| Omeprazole | 66 |
| Levothyroxine Sodium | 58 |
| Amlodipine Besylate | 56 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 54 |
| Escitalopram Oxalate | 54 |
| Metformin Hcl | 50 |
| Furosemide | 47 |
| Ozempic Semaglutide | 46 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Student in an Organized Health Care Education/Training Program Overview
How MARK BOULES, M.D. fits within the Student in an Organized Health Care Education/Training Program landscape nationally.
MARK BOULES, M.D.'s 2,022 claims are above the specialty average of 459.
Nearby Student in an Organized Health Care Education/Training Program Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BOULES.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is MARK BOULES, M.D.'s specialty? ▼
How much does MARK BOULES, M.D. prescribe under Medicare Part D? ▼
Where is MARK BOULES, M.D. located? ▼
What is MARK BOULES, M.D.'s NPI number? ▼
Does MARK BOULES, M.D. prescribe more brand-name or generic drugs? ▼
Does MARK BOULES, M.D. prescribe opioids? ▼
How many Student in an Organized Health Care Education/Training Program providers are there in the US? ▼
What drugs does MARK BOULES, M.D. prescribe most often? ▼
Does MARK BOULES, M.D. accept Medicare? ▼
How can I verify MARK BOULES, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology